Have a personal or library account? Click to login
Selected Aspects of Angiogensis in Haematological Malignancies Cover

Selected Aspects of Angiogensis in Haematological Malignancies

Medical Journal of Cell Biology
Volume 3 (2011): Issue 2 (June 2011)
By: Patrycja Sujka-Kordowska,  Agnieszka Malińska and  Maciej Zabel  
Open Access
|Oct 2014

References

  1. [1] ABOUDOLA S, KINI AR., Angiogenesis in lymphoproliferative disorders: a therapeutic target? Curr Opin Hematol 2005; 12(4): 279-83.10.1097/01.moh.0000168521.76120.7b15928484
    Open DOISearch in Google Scholar
  2. [2] ACHEN MG, GAD JM, STACKER SA, WILKS AF. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors 1997; 15(1): 69-80.10.3109/089771997090021139401819
    Open DOISearch in Google Scholar
  3. [3] AGUAYO A, KANTARJIAN H, MANSHOURI T, GIDEL C, ESTEY E, THOMAS D, KOLLER C, ESTROV Z, O'BRIEN S, KEATING M, FREIREICH E, ALBITAR M. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96(6): 2240-2245.10.1182/blood.V96.6.2240
    Search in Google Scholar
  4. [4] AVRAMIS IA, PANOSYAN EH, DOREY F, HOLCENBERG JS, AVRAMIS VI. Children's Oncology Group., Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962. Clin Cancer Res 2006; 12(23): 6978-6984. 10.1158/1078-0432.CCR-06-114017145817
    Open DOISearch in Google Scholar
  5. [5] BACHELDER RE, CRAGO A, CHUNG J, WENDT MA, SHAW LM, ROBINSON G, MERCURIO AM. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 61(15): 5736-5740.
    Search in Google Scholar
  6. [6] BATES DO, HILLMAN NJ, WILLIAMS B, NEAL CR, POCOCK TM. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 2002; (6): 581-97.10.1046/j.1469-7580.2002.00066.x157075112162726
    Open DOISearch in Google Scholar
  7. [7] BATTEGAY EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995; 73(7): 333-346.10.1007/BF001928858520966
    Search in Google Scholar
  8. [8] BELLÓN T, CORBÍ A, LASTRES P, CALÉS C, CEBRIÁN M, VERA S, CHEIFETZ S, MASSAGUE J, LETARTE M, BERNABÉU C. Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 1993; 23(9): 2340-2345.10.1002/eji.18302309438370410
    Open DOISearch in Google Scholar
  9. [9] BENJAMIN LE, KESHET E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997; 94(16): 8761-876610.1073/pnas.94.16.8761231189238051
    Open DOISearch in Google Scholar
  10. [10] BOGAR LJ, BARTULA LL, PARKMAN HP, MYERS SI. Enhanced bradykinin-stimulated prostaglandin release in the acutely inflamed guinea pig gallbladder is due to new synthesis of cyclooxygenase 1 and prostacyclin synthase. J Surg Res 1999; 84(1): 71-76.10.1006/jsre.1999.561210334892
    Search in Google Scholar
  11. [11] BOULOUMIÉ A, DREXLER HC, LAFONTAN M, BUSSE R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998; 83(10): 1059-1066.10.1161/01.RES.83.10.10599815153
    Open DOISearch in Google Scholar
  12. [12] BREIER G. Angiogenesis in embryonic development--a review. Placenta 2000; 21 Suppl A: S11-15.10.1053/plac.1999.0525
    Open DOISearch in Google Scholar
  13. [13] BROOKS PC, STRÖMBLAD S, KLEMKE R, VISSCHER D, SARKAR FH, CHERESH DA. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995; 96(4): 1815-1822.10.1172/JCI118227
    Open DOISearch in Google Scholar
  14. [14] CARMELIET P. Angiogenesis in health and disease. Nat Med 2003; 9(6): 653-66010.1038/nm0603-653
    Open DOISearch in Google Scholar
  15. [15] CARMELIET P, JAIN RK. Angiogenesis in cancer and other diseases. Nature 2000; 407(6801): 249-257.10.1038/35025220
    Search in Google Scholar
  16. [16] CARMELIET P, MOONS L, LUTTUN A, VINCENTI V, COMPERNOLLE V, DE MOL M, WU Y, BONO F, DEVY L, BECK H, SCHOLZ D, ACKER T, DIPALMA T, DEWERCHIN M, NOEL A, STALMANS I, BARRA A, BLACHER S, VANDENDRIESSCHE T, PONTEN A, ERIKSSON U, PLATE KH, FOIDART JM, SCHAPER W, CHARNOCK-JONES DS, HICKLIN DJ, HERBERT JM, COLLEN D, PERSICO MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7(5): 575-583. 10.1038/87904
    Open DOISearch in Google Scholar
  17. [17] CHEIFETZ S, BELLÓN T, CALÉS C, VERA S, BERNABEU C, MASSAGUÉ J, LETARTE M. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992; 267(27): 19027-19030.10.1016/S0021-9258(18)41732-2
    Search in Google Scholar
  18. [18] DALLAS NA, SAMUEL S, XIA L, FAN F, GRAY MJ, LIM SJ, ELLIS LM, Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 2008; 14(7): 1931-1937.10.1158/1078-0432.CCR-07-447818381930
    Open DOISearch in Google Scholar
  19. [19] DE BONT ES, NEEFJES VM, ROSATI S, VELLENGA E, KAMPS WA. New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter? Leuk Lymphoma 2002; 43(10): 1901-1909.10.1080/104281902100001584412481883
    Open DOISearch in Google Scholar
  20. [20] DÜWEL A, ELENO N, JERKIC M, AREVALO M, BOLAÑOS JP, BERNABEU C, LÓPEZNOVOA JM, Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice. Tumour Biol 2007; 28(1): 1-8.10.1159/00009704017108712
    Search in Google Scholar
  21. [21] EGGERT A, IKEGAKI N, KWIATKOWSKI J, ZHAO H, BRODEUR GM, HIMELSTEIN BP, Highlevel expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 2000; 6(5): 1900-1908.
    Search in Google Scholar
  22. [22] ELICEIRI BP, CHERESH DA. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103(9): 1227-1230.10.1172/JCI686940836010225964
    Open DOISearch in Google Scholar
  23. [23] FERRARA N, GERBER HP, LECOUTER J. The biology of VEGF and its receptors. Nat Med 2003; 9(6): 669-67610.1038/nm0603-669
    Open DOISearch in Google Scholar
  24. [24] FOLKMAN J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1(1): 27-31.10.1038/nm0195-27
    Open DOISearch in Google Scholar
  25. [25] FOLKMAN J. Tumor angiogenesis. Adv Cancer Res 1985; 43: 175-203.10.1016/S0065-230X(08)60946-X
    Open DOISearch in Google Scholar
  26. [26] FONSATTI E, DEL VECCHIO L, ALTOMONTE M, SIGALOTTI L, NICOTRA MR, CORAL S, NATALI PG, MAIO M. Endoglin: An accessory component of the TGF-beta-binding receptorcomplex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 2001; 188(1): 1-7.10.1002/jcp.1095
    Open DOISearch in Google Scholar
  27. [27] FONSATTI E, JEKUNEN AP, KAIREMO KJ, CORAL S, SNELLMAN M, NICOTRA MR, NATALI PG, ALTOMONTE M, MAIO M. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res 2000; 6(5): 2037-2043.
    Search in Google Scholar
  28. [28] FOSS HD, ARAUJO I, DEMEL G, KLOTZBACH H, HUMMEL M, STEIN H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol 1997; 183(1): 44-50.10.1002/(SICI)1096-9896(199709)183:1<;44::AID-PATH1103>3.0.CO;2-I
    Open DOISearch in Google Scholar
  29. [29] GERBER HP, VU TH, RYAN AM, KOWALSKI J, WERB Z. FERRARA N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5(6): 623-628.10.1038/9467
    Search in Google Scholar
  30. [30] GOUGOS A, LETARTE M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 1988; 141(6): 1925-1933.
    Search in Google Scholar
  31. [31] GOUMANS MJ, LIU Z, TEN DIJKE P. TGF-beta signaling in vascular biology and dysfunction. Cell Res 2009; 19(1): 116-127.10.1038/cr.2008.326
    Open DOISearch in Google Scholar
  32. [32] GUERRERO-ESTEO M, SANCHEZ-ELSNER T, LETAMENDIA A, BERNABEU C. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem 2002; 277(32): 29197-29209.10.1074/jbc.M111991200
    Search in Google Scholar
  33. [33] HANAHAN D, FOLKMAN J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86(3): 353-36410.1016/S0092-8674(00)80108-7
    Open DOISearch in Google Scholar
  34. [34] HOOD JD, MEININGER CJ, ZICHE M, GRANGER HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998; 274(3 Pt 2): H1054-105810.1152/ajpheart.1998.274.3.H1054
    Search in Google Scholar
  35. [35] HU Q, DEY AL, YANG Y, SHEN Y, JILANI IB, ESTEY EH, KANTARJIAN HM, GILES FJ, ALBITAR M. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 2004; 100(9): 1884-1891.10.1002/cncr.20187
    Search in Google Scholar
  36. [36] HURWITZ H, FEHRENBACHER L, NOVOTNY W, CARTWRIGHT T, HAINSWORTH J, HEIM W, BERLIN J, BARON A, GRIFFING S, HOLMGREN E, FERRARA N, FYFE G, ROGERS B, ROSS R, KABBINAVAR F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350(23): 2335-2342.10.1056/NEJMoa032691
    Search in Google Scholar
  37. [37] HUSSONG JW, RODGERS GM, SHAMI PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95(1): 309-313.10.1182/blood.V95.1.309
    Search in Google Scholar
  38. [38] JERKIC M, RIVAS-ELENA JV, PRIETO M, CARRÓN R, SANZ-RODRÍGUEZ F, PÉREZBARRIOCANAL F, RODRÍGUEZ-BARBERO A, BERNABÉU C, LÓPEZ-NOVOA JM. Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 2004; 18(3): 609-611.10.1096/fj.03-0197fje
    Search in Google Scholar
  39. [39] KEYHANI A, JENDIROBA DB, FREIREICH EJ. Angiogenesis and leukemia. Leuk Res 2001; 25(8): 639-645.10.1016/S0145-2126(00)00161-2
    Open DOISearch in Google Scholar
  40. [40] KIVIVUORI SM, SIITONEN S, PORKKA K, VETTENRANTA K, ALITALO R, SAARINENPIHKALA U. Expression of vascular endothelial growth factor receptor 3 and Tie1 tyrosine kinase receptor on acute leukemia cells. Pediatr Blood Cancer 2007; 48(4): 387-392.10.1002/pbc.2085716685739
    Search in Google Scholar
  41. [41] KOERSELMAN J, VAN DER GRAAF Y, DE JAEGERE PP, GROBBEE DE, Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 2003; 107(19): 2507-2511.10.1161/01.CIR.0000065118.99409.5F12756191
    Open DOISearch in Google Scholar
  42. [42] KOOMAGI R, ZINTL F, SAUERBREY A, VOLM M. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res 2001; 7(11): 3381-3384.
    Search in Google Scholar
  43. [43] KUMAR S, GHELLAL A, LI C, BYRNE G, HABOUBI N, WANH JM, BUNDRED N. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 1999; 59(4): 856-861
    Search in Google Scholar
  44. [44] LI C, ISSA R, KUMAR P, HAMPSON IN, LOPEZ-NOVOA JM, BERNABEU C, KUMAR S. CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 2003; 116 (Pt 13): 2677-2685.10.1242/jcs.0047012746487
    Search in Google Scholar
  45. [45] LI DY, SORENSEN LK, BROOKE BS, URNESS LD, DAVIS EC, TAYLOR DG, BOAK BB, WENDEL DP. Defective angiogenesis in mice lacking endoglin. Science 1999; 284(5419): 1534-1537.10.1126/science.284.5419.153410348742
    Search in Google Scholar
  46. [46] LI W, JI ZL, ZHUO GC, XU RJ, WANG J, JIANG HR. Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice. Med Oncol 2010; 27(1): 98-10410.1007/s12032-009-9179-y19235530
    Open DOISearch in Google Scholar
  47. [47] LIN RY, ARGENTA PA, SULLIVAN KM, ADZICK NS. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients. Clin Cancer Res 1995; 1(3): 327-331.
    Search in Google Scholar
  48. [48] LIU Y, JOVANOVIC B, PINS M, LEE C, BERGAN RC. Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene 2002; 21(54): 8272-8281.10.1038/sj.onc.1206117
    Open DOISearch in Google Scholar
  49. [49] LUTTUN A, BRUSSELMANS K, FUKAO H. TJWA M, UESHIMA S, HERBERT JM, MATSUO O, COLLEN D, CARMELIET P, MOONS L. Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem Biophys Res Commun 2002; 295(2): 428-43410.1016/S0006-291X(02)00677-0
    Search in Google Scholar
  50. [50] LYU CJ, RHA SY, WON SC. Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia. Yonsei Med J 2007; 48(2): 171-175.10.3349/ymj.2007.48.2.171
    Open DOISearch in Google Scholar
  51. [51] MAEDA K, CHUNG YS, OGAWA Y, TAKATSUKA S, KANG SM, OGAWA M, SAWADA T, SOWA M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77(5): 858-863.10.1002/(SICI)1097-0142(19960301)77:5<;858::AID-CNCR8>3.0.CO;2-A
    Open DOISearch in Google Scholar
  52. [52] MAGLIONE D, GUERRIERO V, VIGLIETTO G, DELLI-BOVI P, PERSICO MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 1991; 88(20): 9267-9271.10.1073/pnas.88.20.9267
    Open DOISearch in Google Scholar
  53. [53] MAGLIONE D, GUERRIERO V, VIGLIETTO G, FERRARO MG, APRELIKOVA O, ALITALO K, DEL VECCHIO S, LEI KJ, CHOU JY, PERSICO M.G. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 1993; 8(4): 925-931.
    Search in Google Scholar
  54. [54] MAISONPIERRE PC, SURI C, JONES PF, BARTUNKOVA S, WIEGAND SJ, RADZIEJEWSKI C, COMPTON D, MCCLAIN J, ALDRICH TH, PAPADOPOULOS N, DALY TJ, DAVIS S, SATO TN, YANCOPOULOS GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277(5322): 55-60.10.1126/science.277.5322.55
    Search in Google Scholar
  55. [55] MAKRILIA N, LAPPA T, XYLA V, NIKOLAIDIS I, SYRIGOS K. The role of angiogenesis in solid tumours: an overview. Eur J Intern Med 2009; 20(7): 663-671 10.1016/j.ejim.2009.07.009
    Open DOISearch in Google Scholar
  56. [56] MIZIA-MALARZ A, SOBOL G, WOŚ H. Angiogeneza w przewlekłych schorzeniach zapalnych i nowotworowych. Pol Merk Lek 2008; XXIV, 141: 185-189
    Search in Google Scholar
  57. [57] MURAKAMI M, MATSUMOTO R, URADE Y, AUSTEN KF, ARM JP. c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells. J Biol Chem 1995; 270(7): 3239-3246. 10.1074/jbc.270.7.3239
    Search in Google Scholar
  58. [58] MURPHY JF, FITZGERALD DJ. Vascular endothelial growth factor induces cyclooxygenasedependent proliferation of endothelial cells via the VEGF-2 receptor. FASEB J 2001; 15(9): 1667-1669.10.1096/fj.00-0757fje
    Search in Google Scholar
  59. [59] NACOV E. Tumor angiogenesis formation of vessels de novo at germ cell tumors. Cancer 1990; 66(5): 916-922.10.1002/1097-0142(19900901)66:5<;916::AID-CNCR2820660517>3.0.CO;2-M
    Open DOISearch in Google Scholar
  60. [60] NORÉN-NYSTRÖM U, HEYMAN M, FRISK P, GOLOVLEVA I, SUNDSTRÖM C, PORWIT A, ROOS G, BERGH A, FORESTIER E. Vascular density in childhood acute lymphoblastic leukemia correlates to biological factors and outcome. Br J Haematol 2009; 146(5): 521-53010.1111/j.1365-2141.2009.07796.x
    Open DOISearch in Google Scholar
  61. [61] OXMANN D, HELD-FEINDT J, STARK AM, HATTERMANN K, YONEDA T, MENTLEIN R. Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype. Oncogene 2008; 27(25): 3567-3575.10.1038/sj.onc.1211025
    Open DOISearch in Google Scholar
  62. [62] OZER E, SARIALIOGLU F, CETINGOZ R, YÜCEER N, CAKMAKCI H, OZKAL S, OLGUN N, UYSAL K, CORAPCIOGLU F, CANDA S. Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study. Pathol Res Pract 2004; 200 (7-8): 501-509.10.1016/j.prp.2004.04.009
    Search in Google Scholar
  63. [63] PADRO T, RUIZ S, BIEKER R, BÜRGER H, STEINS M, KIENAST J, BÜCHNER T, BERDEL WE, MESTERS RM. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637-2644.10.1182/blood.V95.8.2637
    Search in Google Scholar
  64. [64] PEPPER MS, FERRARA N, ORCI L, MONTESANO R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991 Dec 16; 181(2): 902-90610.1016/0006-291X(91)91276-I
    Search in Google Scholar
  65. [65] PEREZ-ATAYDE AR, SALLAN SE, TEDROW U, CONNORS S, ALLRED E, FOLKMAN J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150(3): 815-821.
    Search in Google Scholar
  66. [66] PERSICO MG, VINCENTI V, DIPALMA T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Curr Top Microbiol Immunol 1999; 237: 31-40.10.1007/978-3-642-59953-8_2
    Search in Google Scholar
  67. [67] PRICE DJ, MIRALEM T, JIANG S, STEINBERG R, AVRAHAM H. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 2001; 12(3): 129-135.
    Search in Google Scholar
  68. [68] PULE MA, GULLMANN C, DENNIS D, MCMAHON C, JEFFERS M, SMITH OP. Increased angiogenesis in bone marrow of children with acute lymphoblastic leukemia has no prognostic significance. Br J Haematol 2002; 118(4): 991-998.10.1046/j.1365-2141.2002.03761.x
    Open DOISearch in Google Scholar
  69. [69] QU R, SILVER MM, LETARTE M. Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation. Cell Tissue Res 1998; 292(2): 333-343.10.1007/s004410051064
    Search in Google Scholar
  70. [70] RADWAŃSKA U [red.] Białaczki u dzieci. Volumed, Wrocław ,1998: 17-89
    Search in Google Scholar
  71. [71] RAK J, FILMUS J, KERBEL RS. Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer 1996; 32A(14): 2438-2450.10.1016/S0959-8049(96)00396-6
    Open DOISearch in Google Scholar
  72. [72] RATAJCZAK MZ, RATAJCZAK J, MACHALINSKI B, MAJKA M, MARLICZ W, CARTER A, PIETRZKOWSKI Z, GEWIRTZ AM. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth. Br J Haematol 1998; 103(4): 969-979.10.1046/j.1365-2141.1998.01076.x9886308
    Open DOISearch in Google Scholar
  73. [73] RISAU W, FLAMME I. Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11: 73-91.10.1146/annurev.cb.11.110195.000445
    Open DOISearch in Google Scholar
  74. [74] RISTIMÄKI A, NARKO K, ENHOLM B, JOUKOV V, ALITALO K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998; 273(14): 8413-841810.1074/jbc.273.14.8413
    Search in Google Scholar
  75. [75] SALES KJ, KATZ AA, HOWARD B, SOETERS RP, MILLAR RP, JABBOUR HN. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 2002; 62(2): 424-432
    Search in Google Scholar
  76. [76] SANO H, NOGUCHI T, MIYAJIMA A, HASHIMOTO Y, MIYACHI H. Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitors. Bioorg Med Chem Lett 2006; 16(11): 3068-307210.1016/j.bmcl.2006.02.021
    Search in Google Scholar
  77. [77] SATO N, BEITZ JG, KATO J, YAMAMOTO M, CLARK JW, CALABRESI P, RAYMOND A, FRACKELTON AR JR. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993;142(4):1119-1130.
    Search in Google Scholar
  78. [78] SCHNEIDER N, LANZ S, RAMER R, SCHAEFER D, GOPPELT-STRUEBE M. Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids. J Neurochem 2001; 77(2): 416-424.10.1046/j.1471-4159.2001.00264.x
    Open DOISearch in Google Scholar
  79. [79] SENGER DR, GALLI SJ, DVORAK AM, PERRUZZI CA, HARVEY VS, DVORAK HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 25;219(4587): 983-985.10.1126/science.6823562
    Search in Google Scholar
  80. [80] SEO Y, BABA H, FUKUDA T, TAKASHIMA M, SUGIMACHI K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000; 88(10): 2239-2245.10.1002/(SICI)1097-0142(20000515)88:10<;2239::AID-CNCR6>3.0.CO;2-V
    Open DOISearch in Google Scholar
  81. [81] SHIH TT, HOU HA, LIU CY, CHEN BB, TANG JL, CHEN HY, WEI SY, YAO M, HUANG SY, CHOU WC, HSU SC, TSAY W, YU CW, HSU CY, TIEN HF, YANG PC. Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival. Blood 2009; 113(14): 3161-7.10.1182/blood-2008-08-173104
    Open DOISearch in Google Scholar
  82. [82] SIEGFRIED G, BASAK A, CROMLISH JA, BENJANNET S, MARCINKIEWICZ J, CHRÉTIEN M, SEIDAH NG, KHATIB AM. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 2003; 111(11): 1723-173210.1172/JCI200317220
    Open DOISearch in Google Scholar
  83. [83] SKÖLDENBERG EG, CHRISTIANSSON J, SANDSTEDT B, LARSSON A, LÄCKGREN G, CHRISTOFFERSON R. Angiogenesis and angiogenic growth factors in Wilms tumor. J Urol 2001; 165 (6 Pt 2): 2274-2279.10.1016/S0022-5347(05)66183-6
    Search in Google Scholar
  84. [84] SKÓRA J, BIEGUS J, PUPKA A, BARĆ P, SIKORA J, SZYBER P. Molekularne podstawy angiogenezy. Postepy Hig Med Dosw. (online), 2006; 60: 410-415
    Search in Google Scholar
  85. [85] SMITH SK. Angiogenesis and implantation. Hum Reprod 2000; 15 Suppl 6: 59-66.
    Search in Google Scholar
  86. [86] SMITH WL, DEWITT DL, GARAVITO RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000; 69: 145-182.10.1146/annurev.biochem.69.1.145
    Open DOISearch in Google Scholar
  87. [87] STACHEL D, ALBERT M, MEILBECK R, PAULIDES M, SCHMID I. Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia. Oncol Rep 2007; 17(1): 147-152.10.3892/or.17.1.147
    Search in Google Scholar
  88. [88] STEWART M, TURLEY H, COOK N, PEZZELLA F, PILLAI G, OGILVIE D, CARTLIDGE S, PATERSON D, COPLEY C, KENDREW J, BARNES C, HARRIS AL, GATTER KC. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology 2003; 43(1): 33-39.10.1046/j.1365-2559.2003.01644.x
    Open DOISearch in Google Scholar
  89. [89] ST-JACQUES S, FORTE M, LYE SJ, LETARTE M. Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 1994; 51(3): 405-413.10.1095/biolreprod51.3.405
    Search in Google Scholar
  90. [90] TAMMELA T, ENHOLM B, ALITALO K, PAAVONEN K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65(3): 550-56310.1016/j.cardiores.2004.12.002
    Open DOISearch in Google Scholar
  91. [91] TANABE T, TOHNAI N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 2002; 68-69: 95-11410.1016/S0090-6980(02)00024-2
    Search in Google Scholar
  92. [92] TSUJII M, KAWANO S, TSUJI S, SAWAOKA H, HORI M, DUBOIS RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93(5): 705-716.10.1016/S0092-8674(00)81433-6
    Open DOISearch in Google Scholar
  93. [93] VACCA A, RIBATTI D, IURLARO M, ALBINI A, MINISCHETTI M, BUSSOLINO F, PELLEGRINO A, RIA R, RUSNATI M, PRESTA M, VINCENTI V, PERSICO MG, DAMMACCO F. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res 1998; 28(1): 55-68. 10.1007/s0059900500189594364
    Open DOISearch in Google Scholar
  94. [94] VACCA A, RIBATTI D, RONCALI L, RANIERI G, SERIO G, SILVESTRIS F, DAMMACCO F. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87(3): 503-508.10.1111/j.1365-2141.1994.tb08304.x7527645
    Open DOISearch in Google Scholar
  95. [95] VAN ROYEN N, PIEK JJ, SCHAPER W, BODE C, BUSCHMANN I. Arteriogenesis: mechanisms and modulation of collateral artery development. J Nucl Cardiol 2001; 8(6): 687-693.10.1067/mnc.2001.11892411725265
    Open DOISearch in Google Scholar
  96. [96] VIITA H, MARKKANEN J, ERIKSSON E, NURMINEN M, KINNUNEN K, BABU M, HEIKURA T, TURPEINEN S, LAIDINEN S, TAKALO T, YLA-HERTTUALA S. 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factorinduced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression. Circ Res. 2008; 102(2): 177-184.10.1161/CIRCRESAHA.107.15555617991885
    Open DOISearch in Google Scholar
  97. [97] WITTE MB, BARBUL A. General principles of wound healing. Surg Clin North Am 1997; 77(3): 509-528.10.1016/S0039-6109(05)70566-1
    Open DOISearch in Google Scholar
  98. [98] XU L, COCHRAN DM, TONG RT, WINKLER F, KASHIWAGI S, JAIN RK, FUKUMURA D. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res 2006; 66(8): 3971-3977.10.1158/0008-5472.CAN-04-3085
    Open DOISearch in Google Scholar
  99. [99] YETGIN S, YENICESU I, CETIN M, TUNCER M. Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia. Leuk Lymphoma 2001; 42(1-2): 83-88.10.3109/10428190109097679
    Open DOISearch in Google Scholar
  100. [100] YOKOYAMA C, TANABE T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989; 165(2): 888-894. 10.1016/S0006-291X(89)80049-X
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10052-011-0002-5 | Journal eISSN: 2544-3577
Journal RSS Feed
Language: English
Page range: 17 - 39
Published on: Oct 15, 2014
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
angiogenesis,
acute lymphoblastic leukemia,
acute myeloid leukamia,
angiogenic factors,
microvessel density
Related subjects:
Life sciences,
Molecular biology,
Biochemistry

© 2014 Patrycja Sujka-Kordowska, Agnieszka Malińska, Maciej Zabel, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 3 (2011): Issue 2 (June 2011)